A key Republican lawmaker accused executives of the three largest pharmacy benefit managers (PBMs) of “abusing” the 340B program during [...] Read More »
Articles by : William Newton, Associate Editor/Senior Writer
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] Read More »
Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...] Read More »
Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...] Read More »
Merck will loosen its 340B contract pharmacy restrictions in Minnesota and Missouri, becoming the first drugmaker to officially update its [...] Read More »
Sen. J.D. Vance (R-Ohio), whom former President Donald Trump (R) tapped as his running mate on Monday, is a co-sponsor [...] Read More »
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] Read More »
Eligible providers in Texas can now immediately enroll in the 340B program without waiting for the normal quarterly registration period [...] Read More »
Certain hospitals’ failure to pass 340B savings on to patients is a leading cause of medical debt, two Republican lawmakers [...] Read More »
The Centers for Medicare & Medicaid Services (CMS) has outlined how it plans to identify 340B claims to remove when [...] Read More »